STUDY DESIGN: Basic science, biologic study. OBJECTIVE: To determine the potential benefits of using resveratrol (RSV) for intervertebral disc (IVD) matrix repair and regeneration. SUMMARY OF BACKGROUND DATA: The phytoestrogen RSV is a natural compound found in various plants including grapes and red wines. RSV has been reported to provide a protective effect on articular cartilage in rabbit models for arthritis, but its effect on spine cartilage is unknown. METHODS.: We studied the effect of RSV on bovine IVD cartilage homeostasis by assessing MMP-13 (potent catabolic factor) production, proteoglycan (PG) accumulation and synthesis, and the interaction between RSV and known catabolic factors such as bFGF or IL-1. To understand the molecular mechanisms by which RSV modulates MMP-13 and PG production, we also investigated its downstream target regulatory molecules. RESULTS: Stimulation of bovine disc cells cultured in monolayer with bFGF or IL-1 augmented the production of MMP-13 and ADAMTS-4 at the transcriptional level and this augmentation was blocked by RSV. Incubation of nucleus pulposus cells with RSV for 21 days significantly increased PG accumulation per cell in a dose-dependent manner, increased PG synthesis, rescued PG losses induced by catabolic reagents bFGF and IL-1, and promoted cell survival to levels seen after incubation with the anabolic protein BMP7 100 ng/mL. Protein-DNA interaction array results suggest that RSV effectively suppresses downstream target molecules of bFGF and IL-1 responsible for oxidative stress, proliferation, and apoptosis. CONCLUSION: Resveratrol is a potent anabolic mediator of bovine IVD cartilage homeostasis, revealing its potential as a unique biologic treatment to slow the progression of IVD degeneration. These data suggests RSV may have considerable promise in the treatment of disc degeneration.
STUDY DESIGN: Basic science, biologic study. OBJECTIVE: To determine the potential benefits of using resveratrol (RSV) for intervertebral disc (IVD) matrix repair and regeneration. SUMMARY OF BACKGROUND DATA: The phytoestrogen RSV is a natural compound found in various plants including grapes and red wines. RSV has been reported to provide a protective effect on articular cartilage in rabbit models for arthritis, but its effect on spine cartilage is unknown. METHODS.: We studied the effect of RSV on bovineIVD cartilage homeostasis by assessing MMP-13 (potent catabolic factor) production, proteoglycan (PG) accumulation and synthesis, and the interaction between RSV and known catabolic factors such as bFGF or IL-1. To understand the molecular mechanisms by which RSV modulates MMP-13 and PG production, we also investigated its downstream target regulatory molecules. RESULTS: Stimulation of bovine disc cells cultured in monolayer with bFGF or IL-1 augmented the production of MMP-13 and ADAMTS-4 at the transcriptional level and this augmentation was blocked by RSV. Incubation of nucleus pulposus cells with RSV for 21 days significantly increased PG accumulation per cell in a dose-dependent manner, increased PG synthesis, rescued PG losses induced by catabolic reagents bFGF and IL-1, and promoted cell survival to levels seen after incubation with the anabolic protein BMP7 100 ng/mL. Protein-DNA interaction array results suggest that RSV effectively suppresses downstream target molecules of bFGF and IL-1 responsible for oxidative stress, proliferation, and apoptosis. CONCLUSION:Resveratrol is a potent anabolic mediator of bovineIVD cartilage homeostasis, revealing its potential as a unique biologic treatment to slow the progression of IVD degeneration. These data suggests RSV may have considerable promise in the treatment of disc degeneration.
Authors: Howard An; Scott D Boden; James Kang; Harvinder S Sandhu; William Abdu; James Weinstein Journal: Spine (Phila Pa 1976) Date: 2003-08-01 Impact factor: 3.468
Authors: Helen E Gruber; Gretchen L Hoelscher; Kelly Leslie; Jane A Ingram; Edward N Hanley Journal: Biomaterials Date: 2005-08-11 Impact factor: 12.479
Authors: Yejia Zhang; Howard S An; Shiwen Song; Marc Toofanfard; Koichi Masuda; Gunnar B J Andersson; Eugene J M A Thonar Journal: Am J Phys Med Rehabil Date: 2004-07 Impact factor: 2.159
Authors: Michael B Ellman; Jae-Sung Kim; Howard S An; Jeffrey S Kroin; Xin Li; Di Chen; Dongyao Yan; Doug D Buechter; Keiichi Nakayama; Bo Liu; Stephanie Morgan; Hee-Jeong Im Journal: Arthritis Rheum Date: 2011-12-12
Authors: Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im Journal: Gene Date: 2013-07-02 Impact factor: 3.688
Authors: Nam V Vo; Robert A Hartman; Prashanti R Patil; Makarand V Risbud; Dimitris Kletsas; James C Iatridis; Judith A Hoyland; Christine L Le Maitre; Gwendolyn A Sowa; James D Kang Journal: J Orthop Res Date: 2016-08-12 Impact factor: 3.494
Authors: Hee-Jeong Im; Xin Li; Di Chen; Dongyao Yan; Jaesung Kim; Michael B Ellman; Gary S Stein; Brian Cole; Ranjan Kc; Gabriella Cs-Szabo; Andre J van Wijnen Journal: J Cell Physiol Date: 2012-10 Impact factor: 6.384
Authors: Michael B Ellman; Jae-Sung Kim; Howard S An; Di Chen; Ranjan KC; Jennifer An; Teju Dittakavi; Andre J van Wijnen; Gabriella Cs-Szabo; Xin Li; Guozhi Xiao; Steven An; Su-Gwan Kim; Hee-Jeong Im Journal: Gene Date: 2012-06-10 Impact factor: 3.688
Authors: Luigi A Nasto; Andria R Robinson; Kevin Ngo; Cheryl L Clauson; Qing Dong; Claudette St Croix; Gwendolyn Sowa; Enrico Pola; Paul D Robbins; James Kang; Laura J Niedernhofer; Peter Wipf; Nam V Vo Journal: J Orthop Res Date: 2013-02-06 Impact factor: 3.494
Authors: Jae-Sung Kim; Michael B Ellman; Dongyao Yan; Howard S An; Ranjan Kc; Xin Li; Di Chen; Guozhi Xiao; Gabriella Cs-Szabo; David W Hoskin; Doug D Buechter; Andre J Van Wijnen; Hee-Jeong Im Journal: J Cell Physiol Date: 2013-09 Impact factor: 6.384
Authors: Michael B Ellman; Jaesung Kim; Howard S An; Di Chen; Ranjan Kc; Xin Li; Guozhi Xiao; Dongyao Yan; Joon Suh; Andre J van Wijnen; James H-C Wang; Su-Gwan Kim; Hee-Jeong Im Journal: Gene Date: 2013-04-30 Impact factor: 3.688